Prasugrel for Prevention of Early Saphenous Vein Graft Thrombosis
Phase of Trial: Phase III
Latest Information Update: 15 Jun 2018
At a glance
- Drugs Prasugrel (Primary) ; Aspirin
- Indications Coronary thrombosis
- Focus Therapeutic Use
- 08 Jun 2018 Status changed from active, no longer recruiting to completed.
- 05 Apr 2018 Planned End Date changed from 30 Apr 2018 to 31 May 2018.
- 19 Oct 2017 Planned number of patients changed from 120 to 84.